content

BioAsia 2019 to focus on Disruption in HealthCare, Lifesciences and Biotechnology

Over 1,500 delegates from more than 50 countries to attend Asiaโ€™s largest Biotechnology and Life-sciences forum. About 100 speakers from Government, Industry, Investors and...

International biomed specialist appoints WHP to deliver key expansion project

New state of the art cleanroom facilities will enable a leading international gene and cell therapy company to expand its bioprocessing operations and manufacturing...

โ€˜Japan second fastest pharma growth in 2019โ€™ CPhI Japan report

The Japanese pharma market is expected to grow quickly in 2019 following the release of a new report published ahead of CPhI Japan 2019....

Knight Therapeutics invests up to $125m in Latin America-focused Moksha8

Canada-based Knight Therapeutics has announced it has closed a strategic financing agreement of up to $125m with US-headquartered Moksha8, which specialises in licensing and...

Norvartis invests $115M more in biotech AveXis to double manufacturing

AveXis, a gene therapy company developing treatments for rare and life-threatening neurological diseases that Novartis bought in an $8.7 billion deal, will be creating...

Sapreme Technologies in Alliance to Develop an Oligonucleotide Delivery Platform

Sapreme Technologies, a privately-held biotech company developing a technology platform to enable the cytosolic delivery of macromolecule therapeutics, has been awarded a 6.8 Mโ‚ฌ...

Linum Labs announces Molecule, a software platform and marketplace to accelerate innovation in pharma

Linum Labs, a software development studio that builds blockchain-based solutions, has announced Molecule, a market platform to accelerate innovation in the pharmaceutical and biotech...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read